Skip to main content
VAXX BACK ON TRACK

AstraZeneca Resumes Vaccine Trial in U.S. After Brazilian Volunteer in Control Group Died

A volunteer in the United Kingdom also fell ill.

2020-10-21T223346Z_1866911461_RC2ANJ9BJ9LP_RTRMADP_3_HEALTH-CORONAVIRUS-BRAZIL-VACCINE_r6lol6

Dado Ruvic/Reuters

AstraZeneca resumed its COVID-19 vaccine trial Friday in the United States after a Brazilian volunteer in the study died last week. The participant, researchers announced days later, had been part of the control group and had not received the experimental drug. The pharmaceutical giant, which is conducting the coronavirus research in conjunction with Oxford University, had paused its U.S. trial on September 6 after a participant in the United Kingdom developed a neurological illness.

Read it at Reuters

TRENDING NOW